Windtree Therapeutics Inc WINT:NASDAQ

RT Quote | NASDAQ | USD
Last | 02/26/21 EST
5.10quote price arrow up+0.06 (+1.09%)
Volume
43,616
52 week range
4.00 - 12.00

...

Loading . . .

KEY STATS

  • Open5.18
  • Day High5.22
  • Day Low5.05
  • Prev Close5.10
  • 52 Week High12.00
  • 52 Week High Date03/04/20
  • 52 Week Low4.00
  • 52 Week Low Date04/30/20
  • Market Cap86.29M
  • Shares Out16.92M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta-0.08
  • 1 Year % Change-57.5

RATIOS/PROFITABILITY

  • EPS (TTM)-3.25
  • P/E (TTM)-1.57
  • Fwd P/E (NTM)-2.91
  • EBITDA (MRQ)-27.77M
  • ROE (MRQ)-50.45%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)39.42%
  • Net Margin (MRQ)-17,387.34%
  • Debt To Equity (MRQ)23.86%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Windtree Therapeutics Inc News

There is no recent news for this security.

Latest WINT News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Windtree Therapeutics, Inc., formerly Discovery Laboratories, Inc., is a biotechnology company. The Company is focused on developing KL4 surfactant therapies for respiratory diseases and other potential applications. The Company operates through the research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products segment. The Company's technology platform includes a...
James Huang
Chairman
Craig Fraser
President
Eric Curtis
Chief Operating Officer
John Hamill CPA
Chief Financial Officer
Joseph Soffer M.D.
Executive Vice President
Address
2600 Kelly Rd Ste 100
Warrington, PA
18976-3652
United States